The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

As demand soared for weight-loss drugs, price signals worked.

Robert F. Kennedy Jr. has given his first network television interview since becoming health secretary to Dr. Jon LaPook.

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...

Cardiovascular effectiveness was observed, largely independent of age, in a cohort of older patients with type 2 diabetes.

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

HealthDay News — Among US adults without diabetes, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) increased from 2018 to 2022, reaching annual prevalence of 0.4% in 2022, according ...

The weight-loss drug revolution has arrived, and the food & beverage industry has begun to evolve in response to suppressed ...